Evidence map›Paper›PMID 25838983›Full record

ArticleTissue barriers2015

Blood cells and endothelial barrier function.

Stephen F Rodrigues, D Neil Granger

Open access · bronzeAbstract read
In one paragraph

Article in Tissue barriers, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 2 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 2 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Role of neutrophils in regulating vascular permeability in inflammatory and autoimmune diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Impaired endothelial function contributes to cardiac dysfunction: role of mitochondrial dynamics.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  15. Review
  16. Review
  17. Frontiers in cellular and infection microbiology · 2025
    Review
  18. Article
  19. Article
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Stephen F RodriguesDepartment of Clinical and Toxicological Analyses; School of Pharmaceutical Sciences; University of Sao Paulo ; Sao Paulo, Brazil.
D Neil GrangerDepartment of Molecular and Cellular Physiology; Louisiana State University Health Sciences Center ; Shreveport, LA USA.
Louisiana State University Health Sciences Center New Orleans · USUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The barrier properties of endothelial cells are critical for the maintenance of water and protein balance between the intravascular and extravascular compartments. An impairment of endothelial barrier function has been implicated in the genesis and/or progression of a variety of pathological conditions, including pulmonary edema, ischemic stroke, neurodegenerative disorders, angioedema, sepsis and cancer. The altered barrier function in these conditions is often linked to the release of soluble mediators from resident cells (e.g., mast cells, macrophages) and/or recruited blood cells. The interaction of the mediators with receptors expressed on the surface of endothelial cells diminishes barrier function either by altering the expression of adhesive proteins in the inter-endothelial junctions, by altering the organization of the cytoskeleton, or both. Reactive oxygen species (ROS), proteolytic enzymes (e.g., matrix metalloproteinase, elastase), oncostatin M, and VEGF are part of a long list of mediators that have been implicated in endothelial barrier failure. In this review, we address the role of blood borne cells, including, neutrophils, lymphocytes, monocytes, and platelets, in the regulation of endothelial barrier function in health and disease. Attention is also devoted to new targets for therapeutic intervention in disease states with morbidity and mortality related to endothelial barrier dysfunction.

Indexed as

AJ, Adherens junctionsANG-1, Angiopoietin 1AQP, AquaporinsBBB, blood brain barriercAMP, 3'-5'-cyclic adenosine monophosphateCNS, Central nervous systemCOPD, Chronic obstructive pulmonary diseaseEAE, Experimental autoimmune encephalomyelitisEndothelial barrierEPAC1, Exchange protein activated by cyclic AMPERK1/2, Extracellular signal-regulated kinases 1 and 2erythrocytesFA, Focal adhesionsFAK, focal adhesion tyrosine kinaseFoxO1, Forkhead box O1GAG, GlycosaminoglycansGDNF, Glial cell-derived neurotrophic factorGJ, Gap junctionsGPCR, G-protein coupled receptorsGTPase, Guanosine 5'-triphosphataseHMGB-1, High mobility group box 1HRAS, Harvey rat sarcoma viral oncogene homologICAM-1, Intercellular adhesion molecule 1IL-1β, Interleukin 1 betaIP3, Inositol 1,4,5-triphosphateJAM, Junctional adhesion moleculesleukocytesMEK, Mitogen-activated protein kinase kinaseMLCK, Myosin light-chain kinaseMLC, Myosin light chainMMP, Matrix metalloproteinasesNO, Nitric oxideOSM, Oncostatin MPAF, Platelet activating factorPDE, PhosphodiesterasePKA, Protein kinase AplateletsPNA, Platelet-neutrophil aggregatespSrc, Phosphorylated SrcRac1, Ras-related C3 botulinum toxin substrate 1Rap1, Ras-related protein 1RhoA, Ras homolog gene family, member AROS, Reactive oxygen speciesS1P, Sphingosine-1-phosphateSCID, Severe combined immunodeficientShp-2, Src homology 2 domain-containing phosphatase 2SOCS-3, Suppressors of cytokine signaling 3Src, Sarcoma family of protein kinasesTEER, Transendothelial electrical resistanceTGF-beta1, Transforming growth factor-beta1TJ, Tight junctionsTNF-, Tumor necrosis factor alphavascular permeabilityVCAM-1, Vascular cell adhesion molecule 1VEGF, Vascular endothelial growth factorVE-PTP, Vascular endothelial receptor protein tyrosine phosphataseVE, Vascular endothelialVVO, Vesiculo-vacuolar organelleZO, Zonula occludens

Identifiers

PMID25838983
PMCPMC4372023
OpenAlexW2076485284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.